EMERGENT BIOSOLUTIONS INC. (EBS) Net margin 2016–2025
EMERGENT BIOSOLUTIONS INC. (EBS) net profit margin by fiscal year — reported net income divided by reported revenue.
7.1%FY2025 · since FY2016: 10.6% → 7.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 7.1% | +25.3 pp |
| FY2024 | -18.3% | +54.2 pp |
| FY2023 | -72.5% | -53.5 pp |
| FY2022 | -18.9% | -31.3 pp |
| FY2021 | 12.4% | -7.3 pp |
| FY2020 | 19.7% | +14.7 pp |
| FY2019 | 4.9% | -3.1 pp |
| FY2018 | 8.0% | -6.7 pp |
| FY2017 | 14.7% | +4.1 pp |
| FY2016 | 10.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice